Generate Biomedicines are working to help cure intractable diseases|Andrew Hedin,Partner,Bessemer Venture Partners 00:10:00
Andrew Hedin is a partner in Bessemer’s Cambridge office. Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry. He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.
